Serving Your Research Globally

Human Biospecimens CRO with a Difference

Our mission

To help bring new treatments and diagnostics to patients

by supporting biomedical research and innovation globally

Who we are

Advancing biomedicine to improve human health depends on continuous research, and human biospecimens are essential to that progress, underpinning the development of new diagnostic tools and therapeutic approaches. IBS GL is a fully compliant biospecimens CRO offering professional services in ethical sourcing, processing and characterization of human biospecimens for research, supporting pharmaceutical and biotechnology companies worldwide with the samples their R&D programs depend on. Through our growing global network, including partner sites in regions still underrepresented in biobanking, we help our clients advance new means of diagnostics and therapy.

  • Clinical Partners Network

    IBS GL operates a network of formally contracted and managed clinical centers covering a wide range of therapeutic areas and geographical regions.

  • Compliance & Traceability

    IBS GL provides its services to customers world-wide in strict compliance with local and international ethical, medical, customs and data protection laws, rules and regulations while ensuring full traceability of biospecimens to the source.

  • Laboratory capabilities

    IBS GL partner laboratories allow for sophisticated and highly customizable, yet standardized across the laboratory network processing and characterization of biospecimens.

The Difference

We focus on regions such as Middle East, Central Asia and Latin America, which are often untapped by the global bio-pharmaceutical research yet represent major populations and growing demand for effective and tailored healthcare solutions.

>650M
Combined population of Middle East, North Africa, Turkey and Central Asia currently exceeds 650 million people. Population of LATAM is another 627 million people.

Ethics and protection of personal data

IBS GL operates in full compliance with local and international ethics and Personal Data protection requirements, strictly adhering to General Data Protection Regulation (GDPR) principles. Donor data are always pseudonymized or anonymized, and are collected, processed and transferred in accordance with applicable Data Protection Laws, with appropriate technical and organizational measures in place to protect against unauthorized access, loss, alteration or disclosure. All Informed Consent Forms (ICF) used for biospecimen collection are approved by an Institutional Review Board (IRB) or Independent Ethics Committee.

Read the full statement

Our foundations

Legality

Collection, processing and transfer of biospecimens performed by IBS GL fully meet all requirements of current local and international laws and regulations.

Ethics

We fully respect and protect the rights and interests of all participants involved in our research projects. Biospecimens are collected only after patients' rights and intended use of biospecimens have been explained to patients and informed consent obtained from them.

Transparency

The origin of biological material can always be traced back to the clinical center that provided it. At the same time we support researchers by only providing associated clinical information required for their study. Patient's personal information is protected and never disclosed.

Quality

IBS GL follows current recommendations of the International Society of Biological and Environmental Repositories (ISBER Best Practices) and requirements of ISO 9001. We ensure that all biospecimens collected from our clinical partners are processed strictly in accordance with quality requirements for laboratory protocols and clinical information management. All procedures are conducted by trained personnel whose qualifications and competencies are regularly verified and further developed.